Pemetrexed Shows Promise in Treating Peritoneal Mesothelioma: Presented at ECCO

Pemetrexed, used alone or in tandem with a platinum agent, shows good response and disease control rates in patients diagnosed with peritoneal mesothelioma.

This entry was posted on Thursday, May 15th, 2008 at 10:27 am and is filed under Mesothelioma News. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.